Cryoport (CYRX) Cash & Equivalents (2010 - 2026)

Cryoport (CYRX) has reported Cash & Equivalents for 17 consecutive years, with $272.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 476.24% year-over-year to $272.9 million; the TTM figure through Mar 2026 stood at $272.9 million (up 476.24% YoY), while the FY2025 annual figure was $250.5 million, up 453.1% from the prior year.
• Cash & Equivalents climbed to $272.9 million in Q1 2026 per CYRX's latest filing, from $250.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $272.9 million in Q1 2026 and bottomed at $28.8 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $89.5 million across 5 years, with a median of $39.3 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 52.35% — and 2025, when it jumped 715.57%.
• Cryoport's Cash & Equivalents stood at $29.2 million in 2022, then gained by 20.38% to $35.2 million in 2023, then rose by 28.69% to $45.3 million in 2024, then soared by 453.1% to $250.5 million in 2025, then rose by 8.95% to $272.9 million in 2026.
• Business Quant data shows CYRX's Cash & Equivalents at $272.9 million in Q1 2026, $250.5 million in Q4 2025, and $255.8 million in Q3 2025.